Company Filing History:
Years Active: 2022
Title: Ravindra Bapurao Kadam: Innovator in Vaccine Development
Introduction
Ravindra Bapurao Kadam is a notable inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of immunology, particularly in the development of multivalent vaccine compositions. His innovative work aims to enhance the prevention and prophylaxis of various infections.
Latest Patents
Ravindra Bapurao Kadam holds a patent for a multivalent vaccine composition. This stable and immunogenic combination vaccine comprises a mixture of antigens designed to prevent infections caused by Rotavirus, Poliomyelitis virus, Haemophilus influenzae, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, and Hepatitis B virus. The vaccine includes significantly dose-reduced Salk-IPV or Sabin-IPV antigens, injectable heat-inactivated Rotavirus antigens, Hib PRP-carrier protein conjugates, whole cell pertussis antigens, and homogeneous fractions of Diphtheria and Tetanus toxoids. The innovative approach involves individually adsorbing antigens on alum hydroxide and utilizing a specific order of addition during blending to ensure maximum efficacy.
Career Highlights
Throughout his career, Ravindra has worked with prominent organizations such as the Serum Institute of India Private Limited and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to significant advancements in vaccine technology.
Collaborations
Ravindra has collaborated with esteemed colleagues, including Rajeev Mhalasakant Dhere and Sambhaji Shankar Pisal. These partnerships have further enriched his research and development efforts in the field of immunology.
Conclusion
Ravindra Bapurao Kadam's contributions to vaccine development exemplify his commitment to public health and innovation. His work in creating effective multivalent vaccine compositions is a testament to his expertise and dedication to combating infectious diseases.